Canagliflozin and Metformin Extended-Release Tablets and Carbamazepine Extended-Release Capsules (Carbatrol)
Determining the interaction of Canagliflozin and Metformin Extended-Release Tablets and Carbamazepine Extended-Release Capsules (Carbatrol) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:CarBAMazepine may decrease the blood levels of canagliflozin, which may make the medication less effective in treating your diabetes. Monitor your blood sugar levels closely, and talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the interaction, but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:ADJUST DOSE: Coadministration with uridine diphosphoglucuronate-glucuronosyltransferase (UGT) inducers such as rifampin, phenytoin, phenobarbital, and ritonavir may decrease area under the curve (AUC) of canagliflozin by up to 51%. This may decrease efficacy of canagliflozin.
MANAGEMENT: If coadministration with a UGT inducer is required, consider increasing the dosage of canagliflozin to 300 mg once daily in patients who are currently tolerating 100 mg once daily, have an eGFR greater than 60 mL/min and require additional glycemic control. Other glycemic therapy should be considered for patients with a lower eGFR.
- "Product Information. Invokana (canagliflozin)." Janssen Pharmaceuticals, Titusville, NJ.
- Cerner Multum, Inc. "Australian Product Information." O 0
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: canagliflozin / metformin
Brand name: Invokamet, Invokamet XR
Synonyms: Canagliflozin and metformin, Canagliflozin and Metformin
Generic Name: carbamazepine
Brand name: Carbatrol, Epitol, Equetro, Tegretol, Tegretol XR, Tegretol, Tegretol XR
Synonyms: Carbamazepine, CarBAMazepine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canagliflozin and Metformin Extended-Release Tablets-Carbamazepine Extended-Release Capsules (Equetro)
- Canagliflozin and Metformin Extended-Release Tablets-Carbamazepine Extended-Release Tablets
- Canagliflozin and Metformin Extended-Release Tablets-Carbamazepine Intravenous
- Canagliflozin and Metformin Extended-Release Tablets-Carbamazepine Oral Suspension
- Canagliflozin and Metformin Extended-Release Tablets-Carbamazepine Tablets
- Canagliflozin and Metformin Extended-Release Tablets-Carbaphen 12
- Carbamazepine Extended-Release Capsules (Carbatrol)-Canagliflozin and Metformin Tablets
- Carbamazepine Extended-Release Capsules (Carbatrol)-Canakinumab
- Carbamazepine Extended-Release Capsules (Carbatrol)-Canakinumab Subcutaneous
- Carbamazepine Extended-Release Capsules (Carbatrol)-Canasa
- Carbamazepine Extended-Release Capsules (Carbatrol)-Canasa Pac rectal
- Carbamazepine Extended-Release Capsules (Carbatrol)-Canasa rectal